News
-
-
-
-
PRESS RELEASE
GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
GENFIT highlights long-term commercial opportunity for its MASH Diagnostics Technology. The technology aims to identify patients with 'at-risk MASH' through non-invasive blood-based testing, creating potential for significant revenue streams -
-
-
PRESS RELEASE
GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
GENFIT announces availability of preparatory documents for Annual Combined General Meeting on June 15, 2026. Shareholders can access information on the Company's website. Meeting will be broadcasted live and shareholders can vote online via VOTACCESS platform -
-
-